28.7 C
New York
Friday, June 12, 2026

Tag: modulation

newssourceFORcompanyinformationcontent1marketreleases

ROR Inhibitors Market Expected to Witness Significant Growth Through 2034 Due to the Rising Oncology Research and Pipeline Advancements | DelveInsight

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor (ROR) pathways in cancer and...

ROR Inhibitors Market Expected to Witness Significant Growth Through 2034 Due to the Rising Oncology Research and Pipeline Advancements | DelveInsight

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor (ROR) pathways in cancer and...

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

With over 80 issued patents and 40 pending patent applications, Autonomix is building a comprehensive IP portfolio in nerve-sensing and modulation, strengthening its strategic position in a multi-billion-dollar market opportunity and unlocking potential across cardiovascular, renal, and other high-burden diseases

The Wholesome Company Launches Rē•prev, a Calming Drink Mix for Anxiousness Support

Grapevine, TX, July 21, 2025 (GLOBE NEWSWIRE) -- The Wholesome Company, a wellness brand focused on holistic and evidence-aligned support for mental well-being, is pleased to announce the launch of Rē•prev, a breakthrough nutritional supplement formulated to help individuals reduce anxiousness, manage stress, and improve sleep quality. Designed for rapid absorption and daily use, Rē•prev combines naturally calming ingredients with a flexible, easy-to-use format aimed at supporting emotional resilience in today’s high-stress landscape.

Muscle Gain & Strength Supplements: How CrazyBulk Muscle Building Supplements Boost Strength and Maximize Muscle Performance Fast

Explore how CrazyBulk legal muscle building supplements power muscle gain, improve muscle strength, and unlock next-level muscle performance in 2025. 
Explore how CrazyBulk legal muscle building supplements power muscle gain, improve muscle strength, and unlock next-level muscle performance in 2025.

Crazy Bulk Releases 2025 Transparency Update on Legal Steroid Alternatives

2025 Ingredient Transparency Report Highlights Clean-Label Muscle Stack Reformulations and Global Demand for Safe Performance Alternatives 
2025 Ingredient Transparency Report Highlights Clean-Label Muscle Stack Reformulations and Global Demand for Safe Performance Alternatives

Female Muscle Growth: How CrazyBulk’s Natural Legal Steroids Are Reshaping Muscle Building Supplements For Bodybuilding Women

Discover how CrazyBulk’s natural legal steroids are transforming muscle building supplements for bodybuilding women seeking safe, effective female muscle growth. 
Discover how CrazyBulk’s natural legal steroids are transforming muscle building supplements for bodybuilding women seeking safe, effective female muscle growth.

G-Protein Coupled Receptor (GPCR) Targeting Technologies Market on the Rise

"Highlighting Strategic Alliances and Innovation, the Global GPCR Targeting Market Report Explores the Role of GPCRs in Drug Discovery and Therapeutics, Featuring Key Players...

Topflight Pharma Development Veteran Joins Synendos

Dr. George Garibaldi is named Chief Medical Officer as Synendos transitions from Phase 1 into Phase 2 of its clinical development strategy.

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM)NEW YORK and NORTH CHICAGO, Ill., July 10, 2025...

Glucostra Launches Plant-Based Formula with 20 Ingredients for Natural Blood Sugar and Glucose Balance Support

Clean-Label Botanical Formula Aligns with 2025 Demand for the Best Natural Ingredients in Blood Sugar and Glucose Balance SupportSan Francisco 
Clean-Label Botanical Formula Aligns with 2025 Demand for the Best Natural Ingredients in Blood Sugar and Glucose Balance SupportSan Francisco

BRĒZ THC Drinks Update: 2025 Launch Expands Access to Legal Microdosed THC Beverage Line

In this 2025 product availability update, BRĒZ shares how its legal microdosed THC drinks are redefining the fast-growing functional beverage space—offering adults new access to non-alcoholic, hemp-derived cannabis tonics aligned with the search for the best THC drink alternatives. 
In this 2025 product availability update, BRĒZ shares how its legal microdosed THC drinks are redefining the fast-growing functional beverage space—offering adults new access to non-alcoholic, hemp-derived cannabis tonics aligned with the search for the best THC drink alternatives.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsModulation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers